Don't BLINK, you won't want to miss this UCAAMP lunch
Join UCAAMP for lunch, networking, and to learn more about BLINK 2019
Event Information (passed)
Join UCAAMP on Tuesday, Feb. 12, for an update from Josh Stout, curator of the light-based sculptural installations and parade for BLINK in 2017.
BLINK is a light and art event that spans 20 city blocks in downtown Cincinnati and features large-scale architectural projection mapping and light-based sculptures and installations. Get a sneak peak at the brand-new murals and interactive art for 2019.
Menu
Image courtesy of BLINK
- House salad with assorted toppings and dressing
- Barbeque pulled pork and chicken on a pretzel bun
- Coleslaw
- Potato salad
- Assorted cookies
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.